Navigation Links
Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
Date:9/14/2007

- Article Discussing Analgesic Efficacy of Labopharm's Once-Daily Tramadol

Published in Journal of Pain and Symptom Management - - Company Secures Marketing Partner for Once-Daily Tramadol in Israel -

LAVAL, QC, Sept. 14 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it will present a poster discussing the ability of its once-daily formulation of tramadol to rapidly attain therapeutic plasma levels and provide quick onset of clinically significant analgesia at the XXIV Annual Congress of the European Society of Regional Anaesthesia and Pain Therapy to be held September 12 to 15, 2007 in Valencia, Spain.

The poster presents the results of a multi-centre, open-label, single-dose study examining Labopharm's once-daily formulation of tramadol (200 mg tablets) in patients with moderate to severe acute low back pain. The results of the study suggest that Labopharm's once-daily tramadol formulation provided therapeutic plasma concentrations and onset of analgesic effect within one hour, similar to that cited in the literature for the immediate-release tramadol product. The median duration to onset of pain relief was 45 minutes, at which time 78% of patients had moderate to complete pain relief (43% having a lot to complete pain relief and 35% having moderate pain relief).

"The rapid onset of analgesia suggested by the results of this study of our once-daily tramadol combined with the sustained 24-hour analgesia as demonstrated by our formulation in previous studies should provide a clinically significant benefit to patients," said James R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc.

The poster will be available on Labopharm's web site (http://www.labopharm.com) on Monday, September 17, 2007, following conclusion of the Congress.

Labopharm also announced today that an article discussing the positive outcome of
'/>"/>

SOURCE Labopharm Inc.
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...e highest level of health boosting antioxidants wh...m heart disease to cancer -- shows latest research...ral and northern Europe and northern Asia. Scienti...rden blackcurrant is more nutritious than other fr...
...g on a tip from the Toronto police busted a global...med videos of children being abused. They rescued ...he suspects were running an international child po...sed website. The ring was traced to an Internet ch...
...ancer using prostate specific antigen (PSA) testin...nproven whether population-wide screening with PSA...tate cancer, testing has become common in North A...dicates almost half of Canadian men over 50 years ...
...ected it, and now a scientific study has backed th...drugs do make teens feel older than they really ar...onton, Canada, along with researchers at the Univ...study. As a part of the study they surveyed a ran...
Other Medicine News:Health News:Thirty One Kids Rescued from a Pedophile Ring 2Health News:Dating, Drugs and Sex Make Teens Feel Older Than They are 2
(Date:10/6/2008)...rd-winning video clips feature children, parents d...studies, BETHESDA, Md., Oct. 6 /PRNewswire-USNews...ines, research in children saves lives and improve... the National Institutes of,Health (NIH), "Childre...inicalStudies.nhlbi.nih.gov ), offers parents and ...
(Date:10/6/2008)...ta from SONIC Trial Showed REMICADE Therapy is Mor...cosal Healing Compared with Standard ...a., Oct. 6 /- Data presented for the ...h Crohn,s Disease Naive to,Immunomodulators and Bi...to,the approach to care of patients with moderate ...
(Date:10/6/2008)... - Conference Call Scheduled for 9:00 AM ET...-- Dendreon Corporation (Nasdaq:,DNDN) announced t...lysis of,the Phase 3, randomized, double-blind, pl...e AdenoCarcinoma Treatment, also known as D9902B),...fficacy of the,investigational active cellular imm...
(Date:10/6/2008)...sign Concept of Other Product - Company,s Bioabsor...osium, HONG KONG, Oct. 6 /- Data fro...o-healing stent, OrbusNeich,s Genous Bio-engineere...scatheter Cardiovascular,Therapeutics symposium, T...M.D., Ph.D., of the Academic Medical Center in,Ams...
Breaking Medicine Technology:Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3Risk factors for Parkinsons disease under study 9158 1Risk factors for Parkinsons disease under study 9158 2Parental Control of Eating Leads to Lighter Toddlers 9156 1Parental Control of Eating Leads to Lighter Toddlers 9156 2Parental Control of Eating Leads to Lighter Toddlers 9156 3Start Your Day the Sun Shower 28TM 29 Way 9152 1Start Your Day the Sun Shower 28TM 29 Way 9152 2ASPS Survey Taps Top Markets for Regional Plastic Surgery Data 9148 1ASPS Survey Taps Top Markets for Regional Plastic Surgery Data 9148 2ASPS Survey Taps Top Markets for Regional Plastic Surgery Data 9148 3ASPS Survey Taps Top Markets for Regional Plastic Surgery Data 9148 4
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: